139 related articles for article (PubMed ID: 33159679)
1. Hypergonadotrophic hypogonadism in a patient with transaldolase deficiency: novel mutation in the pentose phosphate pathway.
Lafcı NG; Colak FK; Sahin G; Sakar M; Çetinkaya S; Savas-Erdeve S
Hormones (Athens); 2021 Sep; 20(3):581-585. PubMed ID: 33159679
[TBL] [Abstract][Full Text] [Related]
2. Untargeted metabolomics as an unbiased approach to the diagnosis of inborn errors of metabolism of the non-oxidative branch of the pentose phosphate pathway.
Shayota BJ; Donti TR; Xiao J; Gijavanekar C; Kennedy AD; Hubert L; Rodan L; Vanderpluym C; Nowak C; Bjornsson HT; Ganetzky R; Berry GT; Pappan KL; Sutton VR; Sun Q; Elsea SH
Mol Genet Metab; 2020; 131(1-2):147-154. PubMed ID: 32828637
[TBL] [Abstract][Full Text] [Related]
3. A Rare Cause of Hypergonadotropic Hypogonadism: Transaldolase Deficiency in Two Siblings.
Yildiz M; Onal Z; Yesil G; Kabil TG; Toksoy G; Poyrazoglu S; Bas F; Durmaz O; Darendeliler F
J Clin Res Pediatr Endocrinol; 2023 Feb; ():. PubMed ID: 36825476
[TBL] [Abstract][Full Text] [Related]
4. Transaldolase deficiency in a two-year-old boy with cirrhosis.
Wamelink MM; Struys EA; Salomons GS; Fowler D; Jakobs C; Clayton PT
Mol Genet Metab; 2008 Jun; 94(2):255-8. PubMed ID: 18331807
[TBL] [Abstract][Full Text] [Related]
5. Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure.
Balasubramaniam S; Wamelink MM; Ngu LH; Talib A; Salomons GS; Jakobs C; Keng WT
J Pediatr Gastroenterol Nutr; 2011 Jan; 52(1):113-6. PubMed ID: 21119539
[No Abstract] [Full Text] [Related]
6. Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway.
Verhoeven NM; Huck JH; Roos B; Struys EA; Salomons GS; Douwes AC; van der Knaap MS; Jakobs C
Am J Hum Genet; 2001 May; 68(5):1086-92. PubMed ID: 11283793
[TBL] [Abstract][Full Text] [Related]
7. Hypergonadotropic Hypogonadism Due to Transaldolase Deficiency: Two Cases and Literature Review.
Takaleh A; Abunamous N; AlShamsi A; Alhassani N; Almazrouei R
JCEM Case Rep; 2024 Mar; 2(3):luae028. PubMed ID: 38440129
[TBL] [Abstract][Full Text] [Related]
8. [Transaldolase deficiency - clinical outcome, pathogenesis, diagnostic process].
Lipiński P; Stradomska T; Tylki-Szymańska A
Dev Period Med; 2018; 22(2):187-196. PubMed ID: 30056406
[TBL] [Abstract][Full Text] [Related]
9. Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype.
Eyaid W; Al Harbi T; Anazi S; Wamelink MM; Jakobs C; Al Salammah M; Al Balwi M; Alfadhel M; Alkuraya FS
J Inherit Metab Dis; 2013 Nov; 36(6):997-1004. PubMed ID: 23315216
[TBL] [Abstract][Full Text] [Related]
10. Transaldolase deficiency caused by the homozygous p.R192C mutation of the TALDO1 gene in four Emirati patients with considerable phenotypic variability.
Al-Shamsi AM; Ben-Salem S; Hertecant J; Al-Jasmi F
Eur J Pediatr; 2015 May; 174(5):661-8. PubMed ID: 25388407
[TBL] [Abstract][Full Text] [Related]
11. Clinical, biochemical, and molecular overview of transaldolase deficiency and evaluation of the endocrine function: Update of 34 patients.
Williams M; Valayannopoulos V; Altassan R; Chung WK; Heijboer AC; Keng WT; Lapatto R; McClean P; Mulder MF; Tylki-Szymańska A; Walenkamp ME; Alfadhel M; Alakeel H; Salomons GS; Eyaid W; Wamelink MMC
J Inherit Metab Dis; 2019 Jan; 42(1):147-158. PubMed ID: 30740741
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular characteristics of two transaldolase-deficient patients.
Tylki-Szymanska A; Wamelink MM; Stradomska TJ; Salomons GS; Taybert J; Dąbrowska-Leonik N; Rurarz M
Eur J Pediatr; 2014 Dec; 173(12):1679-82. PubMed ID: 24497183
[TBL] [Abstract][Full Text] [Related]
13. Nephrological abnormalities in patients with transaldolase deficiency.
Loeffen YG; Biebuyck N; Wamelink MM; Jakobs C; Mulder MF; Tylki-Szymańska A; Fung CW; Valayannopoulos V; Bökenkamp A
Nephrol Dial Transplant; 2012 Aug; 27(8):3224-7. PubMed ID: 22510381
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial involvement and erythronic acid as a novel biomarker in transaldolase deficiency.
Engelke UF; Zijlstra FS; Mochel F; Valayannopoulos V; Rabier D; Kluijtmans LA; Perl A; Verhoeven-Duif NM; de Lonlay P; Wamelink MM; Jakobs C; Morava E; Wevers RA
Biochim Biophys Acta; 2010 Nov; 1802(11):1028-35. PubMed ID: 20600873
[TBL] [Abstract][Full Text] [Related]
15. The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review.
Wamelink MM; Struys EA; Jakobs C
J Inherit Metab Dis; 2008 Dec; 31(6):703-17. PubMed ID: 18987987
[TBL] [Abstract][Full Text] [Related]
16. Transaldolase haploinsufficiency in subjects with acetaminophen-induced liver failure.
Oaks Z; Jimah J; Grossman CC; Beckford M; Kelly R; Banerjee S; Niland B; Miklossy G; Kuloglu Z; Kansu A; Lee W; Szonyi L; Banki K; Perl A
J Inherit Metab Dis; 2020 May; 43(3):496-506. PubMed ID: 31769880
[TBL] [Abstract][Full Text] [Related]
17. Transaldolase deficiency in two new patients with a relative mild phenotype.
Tylki-Szymańska A; Stradomska TJ; Wamelink MM; Salomons GS; Taybert J; Pawłowska J; Jakobs C
Mol Genet Metab; 2009 May; 97(1):15-7. PubMed ID: 19299175
[TBL] [Abstract][Full Text] [Related]
18. Apparent Acetaminophen Toxicity in a Patient with Transaldolase Deficiency.
Lee-Barber J; English TE; Britton JF; Sobreira N; Goldstein J; Valle D; Bjornsson HT
JIMD Rep; 2019; 44():9-15. PubMed ID: 29923087
[TBL] [Abstract][Full Text] [Related]
19. Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease.
Valayannopoulos V; Verhoeven NM; Mention K; Salomons GS; Sommelet D; Gonzales M; Touati G; de Lonlay P; Jakobs C; Saudubray JM
J Pediatr; 2006 Nov; 149(5):713-7. PubMed ID: 17095351
[TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus in a girl with PTEN variant and transaldolase deficiency: a novel phenotype.
Al-Mayouf SM; AlTassan RS; AlOwain MA
Clin Rheumatol; 2020 Nov; 39(11):3511-3515. PubMed ID: 32506314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
